JOHNSON, GRAHAM

Johnson, Graham specializes in medicinal chemistry and drug development consulting services for federal biomedical research programs, with deep expertise in supporting early-stage therapeutic discovery and optimization. The contractor provides technical advisory services focused on molecular design, structure-activity relationship analysis, lead optimization, and preclinical compound evaluation, primarily for NIH initiatives such as the Blueprint Neurotherapeutics Network. Their work bridges synthetic organic chemistry and translational pharmacology, delivering targeted consulting to advance novel therapeutics from concept to candidate selection. Key differentiators include hands-on experience in medicinal chemistry workflows, familiarity with NIH funding pipelines, and a proven ability to support complex, high-stakes drug discovery programs under tight scientific and regulatory constraints. The contractor maintains a consistent and focused relationship with the Department of Health and Human Services, particularly through the National Institutes of Health, where they deliver specialized scientific consulting to advance neurotherapeutics and other priority drug development initiatives. Their engagements are not transactional but rather embedded, long-term partnerships centered on technical problem-solving within NIH’s internal research infrastructure. Their primary industry focus lies in professional scientific and technical consulting services, specifically within the pharmaceutical and biomedical research verticals. While classified under NAICS 541990 and 541690, their actual market positioning is as a niche provider of medicinal chemistry expertise to government-funded drug discovery programs, distinguishing themselves through deep domain knowledge rather than broad service breadth. Johnson, Graham operates as a sole proprietorship (2J entity) based in Sanbornton, New Hampshire, with no formal government certifications on record. The business is structured as a micro-enterprise, leveraging individual technical expertise to deliver high-value, specialized consulting services directly to federal science agencies, positioning itself as a trusted independent advisor in the federal biomedical R&D ecosystem.